A Study to Assess Adverse Events and Effectiveness of Intradermally Injected JUVÉDERM® VOLITE™ Gel Filler in Adult Participants in China With Fine Lines Around the Mouth

PHASE3CompletedINTERVENTIONAL
Enrollment

198

Participants

Timeline

Start Date

September 7, 2022

Primary Completion Date

September 3, 2024

Study Completion Date

September 3, 2024

Conditions
Perioral Lines
Interventions
DEVICE

JUVÉDERM® VOLITE™

Injection, intradermal

OTHER

Control

No-treatment control

Trial Locations (11)

100029

China-Japan Friendship Hospital /ID# 252139, Beijing

100034

Peking University First Hospital /ID# 231392, Xicheng District

100144

Plastic Surgery Hospital(Institute), Cams, Pumc /ID# 231394, Beijing

100730

Beijing Hospital /ID# 231393, Beijing

200040

Huashan Hospital, Fudan University /ID# 231395, Shanghai

210008

Nanjing Drum Tower Hospital /ID# 231937, Nanjing

210009

Zhongda Hospital Southeast University /ID# 244045, Nanjing

310003

Hangzhou First People's Hospital /ID# 244111, Hangzhou

430022

Union Hospital Tongji Medical College Huazhong University of Science and Technol /ID# 231396, Wuhan

510630

The Third Affiliated Hospital, Sun Yat-Sen University /ID# 231398, Guangzhou

610041

West China Hospital, Sichuan University /ID# 231740, Chengdu

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY